The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review

Overview of attention for article published in Breast Cancer Research, November 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 5,638 followers.

The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer https://t.co/AumdgLpAYo

Combination of docetaxel, pertuzumab & trastuzumab dramatically increases survival in HER2+ metastatic BC patients https://t.co/7ZFyT3FYaf

New publication: HER2-targeted therapies increase overall survival of patients with metastatic HER2+ #breastcancer https://t.co/7ZFyT3oniH

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.